Saved in:
| Main Authors: | Luis Vollmers, Chen, Shu-Yu, Zacharias, Martin |
|---|---|
| Format: | Recurso digital |
| Language: | English |
| Published: |
Zenodo
2026
|
| Subjects: | |
| Online Access: | https://doi.org/10.5281/zenodo.17527390 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
In vivo magnetic resonance techniques and drug discovery
by: Nicolau Beckmann
Published: (2006)
by: Nicolau Beckmann
Published: (2006)
Herbal Bioactive Targeting Prostate Cancer: A Network Pharmacology and Molecular Mechanism Perspective
by: Shubham Patil1, Ashok Bendgude2, Siddhi Shirahatti3, Ajit Patil4, Godfrey Mathews5
Published: (2026)
by: Shubham Patil1, Ashok Bendgude2, Siddhi Shirahatti3, Ajit Patil4, Godfrey Mathews5
Published: (2026)
Towards the Bioassay Activity Landscape Modeling in Compound Databases
by: José Luis Medina-Franco
Published: (2012)
by: José Luis Medina-Franco
Published: (2012)
Implementing enclosed sterile integrated robotic platforms to improve cell-based screening for drug discovery.
by: Rockliffe, Alice, et al.
Published: (2025)
by: Rockliffe, Alice, et al.
Published: (2025)
Artificial Intelligence: A Transformative Tool in Research and Development
by: Sanika Soor*, Vaishnavi Ajmire, Snehal Vaidya, Dr. Nilesh O. Chachda
Published: (2025)
by: Sanika Soor*, Vaishnavi Ajmire, Snehal Vaidya, Dr. Nilesh O. Chachda
Published: (2025)
Ceritinib Induces Mitochondrial Fragmentation in Thyroid Cancer Cells by Targeting Drp‐1
by: Dongguang Qin, et al.
Published: (2026)
by: Dongguang Qin, et al.
Published: (2026)
DRUG POLICY: WHAT IMPACT DOES IT HAVE ON CHILDREN AND YOUTH?
by: Izabel Friche Passos
Published: (2013)
by: Izabel Friche Passos
Published: (2013)
Discovery of 1‐(arylacetyl)‐2‐phenyl‐pyrrolidine Derivatives as Novel POLθ‐pol Inhibitors via Structure‐Based Virtual Screening and Fragment Fusion
by: Wenlin Fan, et al.
Published: (2025)
by: Wenlin Fan, et al.
Published: (2025)
Green genes from blue greens: challenges and solutions to unlocking the potential of cyanobacteria in drug discovery.
by: Philmus, Benjamin, et al.
Published: (2026)
by: Philmus, Benjamin, et al.
Published: (2026)
Pathogen-specific drug metabolism in tuberculosis: Enzymes, metabolic pathways, and new horizons in therapeutic development.
by: Vijayalakshmi, Periyasamy, et al.
Published: (2026)
by: Vijayalakshmi, Periyasamy, et al.
Published: (2026)
Green Drug Discovery: Leveraging Biodiversity for Sustainable Pharmaceutical Solutions.
by: Singh, Arshdeep, et al.
Published: (2026)
by: Singh, Arshdeep, et al.
Published: (2026)
Chemical proteomics accelerates the target discovery of natural products.
by: He, Shu-Jie, et al.
Published: (2024)
by: He, Shu-Jie, et al.
Published: (2024)
Recent Progress of Molecular Design and Activities of Spleen Tyrosine Kinase (SYK) Inhibitors
by: Jiayi Shen, et al.
Published: (2025)
by: Jiayi Shen, et al.
Published: (2025)
Renal Interstitial Distribution of Full‐Length IgG and Fab Fragments in Unilateral Ureteral Obstruction‐Induced Fibrotic Kidneys
by: Yuki Nakamura, et al.
Published: (2025)
by: Yuki Nakamura, et al.
Published: (2025)
Metabolic Identification Based on Proposed Mass Fragmentation Pathways of the Anabolic Steroid Bolasterone by Gas Chromatography Tandem Mass Spectrometry
by: Anca Raluca Muresan, et al.
Published: (2025)
by: Anca Raluca Muresan, et al.
Published: (2025)
Application of artificial intelligence in clinical trials and drug development
by: Addepalli Lakshmi Abhishek, Rachna Varma, Shweta Anand
Published: (2026)
by: Addepalli Lakshmi Abhishek, Rachna Varma, Shweta Anand
Published: (2026)
Leveraging the Fragment Merging Approach for Synthetizing Novel Selanyl Phenyl Acetamide Thiazolidinedione Hybrids Endowed With Apoptotic Potential for Cancer Treatment
by: Saad Shaaban, et al.
Published: (2025)
by: Saad Shaaban, et al.
Published: (2025)
Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic Innovation.
by: Mehran, Mohammad Javad, et al.
Published: (2026)
by: Mehran, Mohammad Javad, et al.
Published: (2026)
From marine predator to pharmacology: Conotoxin diversity, discovery, and therapeutic potential.
by: Mao, Kai-Lin, et al.
Published: (2026)
by: Mao, Kai-Lin, et al.
Published: (2026)
Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three‐Dimensional Cancer Models PKI
by: Vladislav Lobanov, et al.
Published: (2025)
by: Vladislav Lobanov, et al.
Published: (2025)
Molecular Pathways in Idiopathic Pulmonary Fibrosis: A Review of Novel Insights for Drug Design
by: Dilay Kahvecioglu
Published: (2025)
by: Dilay Kahvecioglu
Published: (2025)
Rising Star: G Protein-coupled Receptors (GPCRs) in Microenvironment Pharmacology and Sensory Perception Pharmacology.
by: Wang, Jia-Le, et al.
Published: (2026)
by: Wang, Jia-Le, et al.
Published: (2026)
Detection of polypharmacy side effects by integrating multiple data sources and convolutional neural networks
by: Lakizadeh, Amir, et al.
Published: (2022)
by: Lakizadeh, Amir, et al.
Published: (2022)
Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP‐1/EGFR Inhibitors
by: Haytham O. Tawfik, et al.
Published: (2026)
by: Haytham O. Tawfik, et al.
Published: (2026)
Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
by: Marwa I. Serag, et al.
Published: (2024)
by: Marwa I. Serag, et al.
Published: (2024)
Identification of Novel Neddylation‐Related Molecular Subtypes in Non‐Small Cell Lung Cancer With Implications for Prognosis and the Immune Landscape
by: Chuli Pan, et al.
Published: (2025)
by: Chuli Pan, et al.
Published: (2025)
Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin‐4‐One Derivatives as Dual EGFR and FGFR Inhibitors
by: Sara Sultan, et al.
Published: (2025)
by: Sara Sultan, et al.
Published: (2025)
Emerging in Diabetic Cardiomyopathy: Molecular Pathways and Targets for Therapeutic Intervention
by: Mansi Vinodkumar Trivedi, et al.
Published: (2025)
by: Mansi Vinodkumar Trivedi, et al.
Published: (2025)
Genai For Drug Discovery And Development
by: Gopalakrishnan Mahadevan
Published: (2025)
by: Gopalakrishnan Mahadevan
Published: (2025)
A review of nature's pharmacy: Unveiling the sources, classes and therapeutic potentials of natural products in drug discovery
by: Muoegbunam, Juliet Chiamaka, et al.
Published: (2025)
by: Muoegbunam, Juliet Chiamaka, et al.
Published: (2025)
Public Health Issues and Drug Abuse Research. Research Issues 30.
by: Glynn, Thomas J., Ed., et al.
Published: (1982)
by: Glynn, Thomas J., Ed., et al.
Published: (1982)
SMART-assisted discovery of scalaranes from the marine sponge Lendenfeldia sp. and its anti-osteoclastogenesis activity.
by: Pham, Quoc-Vu, et al.
Published: (2026)
by: Pham, Quoc-Vu, et al.
Published: (2026)
ADHERENCE TO MEDICATION THERAPY IN USERS OF PSYCHOACTIVE SUBSTANCES
by: Débora Schlotefeldt Siniak
Published: (2013)
by: Débora Schlotefeldt Siniak
Published: (2013)
Decoding of the Role of TREM2 in Neuropathic Pain: Molecular Pathway and Neuroinflammatory Mechanism
by: Nithya Vijayan, et al.
Published: (2025)
by: Nithya Vijayan, et al.
Published: (2025)
NanoMIPs: Molecularly Imprinted Cavities for Smart and Controlled Anti‐Cancer Drug Release
by: Rabab Fatima
Published: (2025)
by: Rabab Fatima
Published: (2025)
Combination of Diosmetin With Chrysin Against Hepatocellular Carcinoma Through Inhibiting PI3K/AKT/mTOR/NF‐кB Signaling Pathway: TCGA Analysis, Molecular Docking, Molecular Dynamics, In Vitro Experiment
by: Xiang Yu, et al.
Published: (2024)
by: Xiang Yu, et al.
Published: (2024)
Exploring Pyrazolo[3,4‐ b ]Pyridine and Spiro‐Oxindole Hybrids as Selective CDK2 or EGFR Inhibitors for Targeted Cancer Therapy: Design, Synthesis, and Molecular Modeling Insights
by: Ahmed K. B. A. W. Farouk, et al.
Published: (2026)
by: Ahmed K. B. A. W. Farouk, et al.
Published: (2026)
Road to Nowhere: Drug Abuse
by: Leibenguth, Charla
Published: (1971)
by: Leibenguth, Charla
Published: (1971)
SAIAME: Semi‐Parameter Adaptation Information‐Assisted Multi‐Objective Evolutionary for Protein‐Ligand Docking
by: Wei Xiao, et al.
Published: (2025)
by: Wei Xiao, et al.
Published: (2025)
Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Novel 2‐Aminothiazole Derivatives as Potential FOXM1 Inhibitors for Triple‐Negative Breast Cancer Therapy and Structure‐Activity Relationship
by: Khaled A. N. Abusharkh, et al.
Published: (2026)
by: Khaled A. N. Abusharkh, et al.
Published: (2026)
Similar Items
-
In vivo magnetic resonance techniques and drug discovery
by: Nicolau Beckmann
Published: (2006) -
Herbal Bioactive Targeting Prostate Cancer: A Network Pharmacology and Molecular Mechanism Perspective
by: Shubham Patil1, Ashok Bendgude2, Siddhi Shirahatti3, Ajit Patil4, Godfrey Mathews5
Published: (2026) -
Towards the Bioassay Activity Landscape Modeling in Compound Databases
by: José Luis Medina-Franco
Published: (2012) -
Implementing enclosed sterile integrated robotic platforms to improve cell-based screening for drug discovery.
by: Rockliffe, Alice, et al.
Published: (2025) -
Artificial Intelligence: A Transformative Tool in Research and Development
by: Sanika Soor*, Vaishnavi Ajmire, Snehal Vaidya, Dr. Nilesh O. Chachda
Published: (2025)